Kaposi sarcoma associated herpesvirus pathogenesis (KSHV)--an update
- PMID: 23769237
- PMCID: PMC3716290
- DOI: 10.1016/j.coviro.2013.05.012
Kaposi sarcoma associated herpesvirus pathogenesis (KSHV)--an update
Abstract
Kaposi sarcoma-associated herpesvirus (KSHV) is the etiological agent of several human malignancies. The virus is able to modulate pro-proliferative pathways to its advantage, while simultaneously inhibiting pro-apoptotic signaling pathways. These functions are carried out by multiple viral proteins acting in concert. The overall outcome is the survival and proliferation of the infected cell. Additionally, the virus also modulates innate immune pathways to allow for prolonged survival of the infected cell following primary infection, and during viral latency. Here we review the latest advances in our knowledge of KSHV pathogenesis.
Copyright © 2013 Elsevier B.V. All rights reserved.
Figures


References
-
- Ray A, Marshall V, Uldrick T, Leighty R, Labo N, Wyvill K, Aleman K, Polizzotto MN, Little RF, Yarchoan R, et al. Sequence analysis of Kaposi sarcoma-associated herpesvirus (KSHV) microRNAs in patients with multicentric Castleman disease and KSHV-associated inflammatory cytokine syndrome. The Journal of infectious diseases. 2012;205:1665–1676. - PMC - PubMed
-
- Damania B, Cesarman E. Kaposi's Sarcoma–Associated Herpesvirus, Chapter 65. Fields Virology, Lippincott Williams & Wilkins. 2013:2080–2128.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources